Northern Trust’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Northern Trust’s Portfolio SNNA Stock Details SNNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-196,339	Closed	-$171K	–	4317
2019 Q2	$171K	Sell	196,339 -11,784	-6%	-$18.4K	﹤0.01%	3858
2019 Q1	$483K	Buy	208,123 +34,782	+20%	+$94.3K	﹤0.01%	3548
2018 Q4	$402K	Buy	173,341 +4,230	+3%	+$37.3K	﹤0.01%	3611
2018 Q3	$2.51M	Buy	169,111 +21,527	+15%	+$342K	﹤0.01%	3090
2018 Q2	$2.24M	Buy	147,584 +22,146	+18%	+$376K	﹤0.01%	3149
2018 Q1	$2.35M	Buy	125,438 +71,863	+134%	+$1.26M	﹤0.01%	3015
2017 Q4	$972K	Buy	53,575 +3,631	+7%	+$76.8K	﹤0.01%	3412
2017 Q3	$1.11M	Buy	+49,944	New	+$1.1M	﹤0.01%	3410

Other funds holding SNNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GSWM

Golden State Wealth Management Santa Ana, California $1.1B AUM 27.5% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Northern Trust's SNNA Position: Q3 2019 in Review

Northern Trust sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q3 2019, closing a stake of 196,339 shares — an estimated $171K sold.

Northern Trust first reported a position in SNNA in Q3 2017 and held it in 8 quarters. The position peaked at $2.51M in Q3 2018. 23 funds tracked by Wall St. Rank hold SNNA as of Q3 2019.

Northern Trust reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
Northern Trust sold 196,339 Sienna Biopharmaceuticals, Inc. shares in Q3 2019, an estimated $171K.
Northern Trust first reported a position in Sienna Biopharmaceuticals, Inc. in Q3 2017 and held it in 8 quarters.
Northern Trust's Sienna Biopharmaceuticals, Inc. position peaked at $2.51M in Q3 2018.
23 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q3 2019.

Based on Northern Trust's 13F filing for Q3 2019, filed 13 Nov 2019.